Occupational Exposure to Silica and Lung Cancer: Pooled Analysis of Two Case-control Studies in Montreal, Canada
Overview
Oncology
Public Health
Affiliations
Background: Respirable crystalline silica is a highly prevalent occupational exposure and a recognized lung carcinogen. Most previous studies have focused on selected high-exposure occupational groups. This study examines the relationship between occupational exposure to silica and lung cancer in an occupationally diverse male population.
Methods: Two large population-based case-control studies of lung cancer were conducted in Montreal, one in 1979-1986 (857 cases, 533 population controls, 1,349 cancer controls) and the second in 1996-2001 (738 cases and 899 controls). Interviews provided descriptive lifetime job histories, smoking histories, and other information. Industrial hygienists translated job histories into histories of exposure to a host of occupational substances, including silica. Relative risk was estimated, adjusting for several potential confounders, including smoking.
Results: The odds ratio for substantial exposure to silica was 1.67 (95% confidence interval, 1.21-2.31) and for any exposure was 1.31 (95% confidence interval, 1.08-1.59). Joint effects between silica and smoking were between additive and multiplicative, perhaps closer to the latter. In this population, it is estimated that approximately 3% of lung cancers were attributable to substantial silica exposure.
Conclusions: The carcinogenicity of inhaled crystalline silica was observed in a population with a wide variety of exposure circumstances.
Impact: The finding of carcinogenicity across a wide range of occupations complements prior studies of specific high-exposure occupations. This suggests that the burden of cancer induced by silica may be much greater than previously thought.
Rey-Brandariz J, Martinez C, Candal-Pedreira C, Perez-Rios M, Varela-Lema L, Ruano-Ravina A Environ Health. 2023; 22(1):82.
PMID: 38031062 PMC: 10687911. DOI: 10.1186/s12940-023-01036-0.
Ge C, Peters S, Olsson A, Portengen L, Schuz J, Almansa J Am J Respir Crit Care Med. 2020; 202(3):412-421.
PMID: 32330394 PMC: 7465090. DOI: 10.1164/rccm.201910-1926OC.
Wang D, Yang M, Liu Y, Ma J, Shi T, Chen W JAMA Netw Open. 2020; 3(4):e202787.
PMID: 32286660 PMC: 7156992. DOI: 10.1001/jamanetworkopen.2020.2787.
Sauve J, Lavoue J, Nadon L, Lakhani R, Senhaji Rhazi M, Bourbonnais R Environ Health. 2019; 18(1):14.
PMID: 30770757 PMC: 6377721. DOI: 10.1186/s12940-019-0451-0.
Global Epidemiology of Lung Cancer.
Barta J, Powell C, Wisnivesky J Ann Glob Health. 2019; 85(1).
PMID: 30741509 PMC: 6724220. DOI: 10.5334/aogh.2419.